March Jobs Data on Deck! 💼

Stocks notched modest gains on Thursday after weekly jobless claims data came in hotter than expected. The Nasdaq jumped 0.7%, while the S&P 500 added 0.3% and the Dow closed flat. The small-cap Russell 2K squeaked out a 0.1%. gain.

This morning, futures are down in early trading. S&P 500 contracts are showing a 0.1% loss.

5 Red-Hot Gold Stocks to Consider Right Now 🥇

There's could still be plenty upside on the table for gold investors.

The precious metal recently broke through a key resistance point at $2,000/ oz...

And the rally is showing no signs of slowing down. Reports of widespread gold buying by central banks could help carry prices past $2,500/ oz. by year end.

If you want a piece of the gold market, but don't know where to start, we've got you covered.

These 5 gold stocks could have incredible upside potential if the gold rally continues.

Get the Tickers & More Details Here

⚪ None

AMC Entertainment is at the top of our premarket lineup again today.

The movie theater meme stock continues to run hot in the wake of a recent court decision that halted the company's efforts to convert its preferred shares.

However, an additional catalyst cam through late Thursday afternoon, when a Form 4 filing revealed insider selling at the company.

According to the filing, Antara Capital dumped more than 11 million shares of AMC Preferred Shares [APE] on April 4th at an average price of $1.67 apiece.

It seems like bearish news, but that's not enough to stop one of America's favorite meme stocks. Shares of AMC are up 9.8% on the news.

My Take: Classic meme stock trading action here. Chasing gains in AMC is always a gamble, so be cautious if you decide to go after this one.

Something is cooking at Finance of America Companies...

The consumer lending stock is heating up after a Form 3 filing revealed president Kristen Sieffert has amassed a 258,521-share position in the company.

Sieffert also controls more than 1 million additional shares via derivative securities and other instruments.

Earlier in the week, FOA began rallying after a Form 4 filing revealed Blackstone had amassed a significant stake in the company.

FOA is up 16.8% this morning, after gaining more than 30.4% in Thursday's session.

My Take: When Blackstone is buying, it's worth a second look. I'm not sure what's going on at FOA, but it could be the prelude to a buyout deal or other major catalyst.

CNS Pharma is moving higher after a key regulatory decision.

The clinical-stage pharma firm said the Competent Authority from the central Ethics Committee in Italy approved its trial evaluating Berubicin for GBM.

The committee approved CNS's application for a potentially pivotal global trial. The trial is now expected to have more than 60 clinical sites across 5 countries.

"We are incredibly pleased to add Italy to our growing portfolio of European countries for this global study," CEO John Climaco said in a press release.

CNSP is one of today's top premarket gainers with a 53.5% rally.

My Take: Anything can happen at a drug trial, so CSP has a lot of uncertainty ahead of it. However, it could see big growth if it can get Berubicin through this pivotal trial successfully.

A new patent award is lifting shares of Vistagen this morning.

Yesterday, the company announced the European Patent Office had approved its patent application for AV-101 an oral NMDAR glycine site antagonist.

The patent relates to the synthesis of AV-101 and certain chemical intermediaries.

Vistagen said the new E.U. patent compliments its previously-granted U.S. patent on the therapeutic compound, which lasts until 2039.

VTGN is up 19.5% on news of the patent approval.

My Take: This is a very low-float stock, and its chart isn't particularly attractive. This stock could see a lot of volatility today.

Freedom Holding Corp [FRHC] ... AM
Tilray [TLRY] ... AM
Cognyte [CGNT] ... AM
Ironnet [IRNT] ... AM